Ensoma
United States · $258.0M raised
- Business Model
- Biotech R&D
- Website
- ensoma.com
- Total Funding
- $258.0M
- Last Round
- $53.0M Venture RoundSep 2025
- Rounds
- 4
About
Genomic medicine company engineering hematopoietic stem cells in vivo to develop durable therapeutic treatments.
Summary
Ensoma is a Biotech company based in United States. It has raised $258.0M in total across 4 rounds, most recently a $53.0M Venture Round round in Sep 2025. Investors include 5AM Ventures, Arix Bioscience and Takeda (JP).
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Sep 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Novel DNA sequencing architecture to scale the ultra low cost whole genome
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company